| 产品详情 |
| Edit |   |
|---|
| Product Name | Astemizole-d3 |
|---|
| Description | Chemical: ~90%Isotopic: ~90%. Labeled Astemizole. Nonsedating-type histamine H1-receptor antagonist. Potential for combination therapy with antivancer drugs such as doxorubicin in resistant leukemia. Antihistaminic. Solubility: As Reported |
|---|
| Size | 1mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 1-[(4-Fluorophenyl)methyl]-N-[1-[2-(4-methoxy-d3-phenyl)ethyl]-4-piperidinyl]-1H-benzimidazol-2-amine; Astemisan-d3; Hismanal-d3; Histamen-d3; Paralergin-d3; R 42512-d3; R 43512-d3; Retolen-d3; Waruzol-d3; |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 2917 |
|---|
| Price | |
|---|
| Order / More Info | Astemizole-d3 from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|